RE:RE:TLT Yep Goldie, I'm not going to argue about managements execution here, it's been lacking, to be kind. I like that they had the idea tho, to get involved in PDTs, find Dr. McFarland, get the necessary contracts signed, patents filed. They do deserve some credit, I hope the new CEO hire will perform better.
It is very hard to ignore those Drs, Patents, The Hospitals they are working with, the overall tech and even the strategy of going after BTD with the FDA.
IF those pieces are proven out in the near term then all this time 'wasted?' in this investment will have been well worth it. :-)
goldn1 wrote:
fasttrack:
The volume today was 90%+ me buying more shares in hopes there would be positibe news on the IND and trial resuming. I don't believe TLT should start another indication until positive data is released to move the stock price higher as more financing would be needed for that and hopefully not at these prices.
I have been wrong everytime I have bought TLT for the past 7 years, but I figured more shares in the 20's would only bring my average down. imo, everything hinges on patients results from the Phase II trial, doesn't matter how many other indications they announce if MIBC fails to produce the efficacy needed to replace the current SOC.
As most know, I am not a fan of management and feel we would be much better off and a lot further along if we had a team that was more experienced and not just looking to line their pockets. But I am a big fan of a successful cancer cure and that is the only reason I have stuck around so long. I don't believe I was able to buy as much as i planned today, so i will be buying more on Monday hoping they can finallyt meet the date of mid-may...
G1